Nemotan (Nimodipine)

Nimodipine selectively blocks L‑type calcium channels on the smooth muscle of cerebral arteries. This inhibition reduces calcium entry, causing the vessels to relax and dilate, which improves cerebral perfusion and lowers the chance of vasospasm after bleeding into the subarachnoid space.

The specific dose of Nemotan is determined by the treating physician based on the patient’s clinical condition, weight, and renal or hepatic function. Prescribers typically follow established guidelines for nimodipine, but the exact regimen should be individualized and confirmed by a qualified healthcare professional.

Safety data for nimodipine in pregnancy and lactation are limited, and the product’s pregnancy category is not definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the prescribing clinician.

To request Nemotan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nemotan (nimodipine) is a selective cerebral vasodilator, whereas alternatives such as nicardipine or clazosentan have broader vascular effects or different mechanisms. Nimodipine’s advantage lies in its preferential action on cerebral vessels, but clinicians consider individual patient factors, drug‑interaction profiles, and local practice guidelines when choosing therapy.

Store Nemotan at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat. Do not use if the packaging is damaged or if the tablets appear discoloured or broken.

Nemotan is taken orally, usually with a glass of water. It can be administered with or without food, but consistent intake with respect to meals helps maintain stable blood levels. Patients should follow the prescriber’s instructions regarding timing and any required dose adjustments.

The most serious adverse events include severe hypotension, which can cause dizziness or fainting, and rare hepatic dysfunction indicated by elevated liver enzymes. Allergic reactions such as rash, itching, or anaphylaxis may also occur. Any sudden drop in blood pressure or signs of liver injury should prompt immediate medical evaluation.

Nemotan should be avoided in patients with known hypersensitivity to nimodipine or any component of the formulation. Caution is advised for individuals with severe hypotension, uncontrolled heart failure, or those taking strong CYP3A4 inhibitors that could raise drug levels. The prescriber must assess each patient’s medical history before initiating therapy.